REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr Sirek Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: All Other Miscellaneous Schools and Instruction | All Other Miscellaneous Ambulatory Health Care Services
Full name: Dr Sirek Sp. z o.o. Profile Updated: January 27, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Dr Sirek Sp. z o.o. is a company based in Poland, with its head office in Bielsko-Biala. The enterprise currently operates in the Ambulatory Health Care Services sector. It was first established on January 26, 2024. From the latest financial highlights, Dr Sirek Sp. z o.o. reported a net sales revenue increase of 243.06% in 2025. Its’ total assets recorded a growth of 51.62%. In 2025, Dr Sirek Sp. z o.o.’s net profit margin decreased by 71.51%.

Headquarters
Ul. 3 Maja 19/7
Bielsko-Biala; Slaskie; Postal Code: 43-300

Contact Details: Purchase the Dr Sirek Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Dr Sirek Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Dr Sirek Sp. z o.o. report to view the information.
Incorporation Date:
January 26, 2024
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Dr Sirek Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
243.06%
Total operating revenue
243.06%
Operating Profit/Loss (EBIT)
-57.9%
EBITDA
-45.47%
Net Profit/Loss for the Period
-58.57%
Total Assets
51.62%
Total Equity
39.44%
Operating Profit Margin (ROS)
-78.48%
Net Profit Margin
-71.51%
Return on Equity (ROE)
-66.92%
Quick Ratio
-3.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?